The cost of screening for diabetes and intermediate hyperglycaemia

Diabetes Res Clin Pract. 2012 Sep;97(3):341-2. doi: 10.1016/j.diabres.2012.05.012. Epub 2012 Jun 9.

Author

Stephen Colagiuri

PMID: 22682947
DOI: 10.1016/j.diabres.2012.05.012

No abstract available

Publication types

Editorial

MeSH terms

Cost-Benefit Analysis
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / diagnosis*
Diabetes Mellitus, Type 2 / economics*
Diabetes Mellitus, Type 2 / epidemiology
Glucose Intolerance / complications
Glucose Intolerance / diagnosis
Glucose Intolerance / economics
Glucose Intolerance / epidemiology
Glucose Tolerance Test / economics
Glucose Tolerance Test / statistics & numerical data
Health Care Costs* / statistics & numerical data
Health Care Costs* / trends
Humans
Hyperglycemia / complications
Hyperglycemia / diagnosis*
Hyperglycemia / economics*
Hyperglycemia / epidemiology
Mass Screening / economics*
Prevalence